Clinical Trial: Panhematin for Prevention of Acute Attacks of Porphyria Panhematin for Prevention of Acute Attacks of Porphyria

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Safety and Efficacy of Panhematin™ for Prevention of Acute Attacks of Porphyria

Brief Summary:

The purpose of this study is to determine if Panhematin is safe and effective for prevention of acute attacks of porphyria.

The study aims to provide high quality evidence for the use on hemin for prevention of acute attacks of porphyria. A separate study is in progress to evaluate the use of Panhematin for treatment of acute attacks of porphyria. Such studies have not been done previously for treating or preventing acute attacks with hemin. The lack of strong evidence for efficacy of hemin for treatment and prevention of attacks limits its availability for patients with acute porphyrias.